At HelioWave, we’re proud to partner with forward-thinking investors who share our vision of creating impactful innovations.
HelioWave is backed by funding from DARPA, NIH, and USDA and support from BARDA BLUE KNIGHT and JLABS Incubator. These resources fuel our mission to advance product and consumer safety testing with state-of-the-art compliance techniques.
HelioWave has utilized non-diluted government funding to support the research activities. Funding includes:
HelioSAFE: A Platform for the Fast, Label-Free, Automated Evaluation of Sterility
DARPA SBIR (Phase I/II)
Contract: HR001121C0178, HR001122C014
Year Start: 2021
HelioQUANT: A Platform for Fast, Label-Free, Automated Evaluation of Bioburden
NIH SBIR (Phase I)
Contract: 1R43AI167567-01A1
Year Start: 2022
HelioCLEAN: Miniaturized system for rapid monitoring of food borne pathogens
USDA SBIR (Phase I)
Contract: USDA-2025-00518
Year Start: 2025
Currently in: Seed stage funding
Status: Open
Stay ahead of HelioWave’s latest milestones, insights, and news by subscribing to our investor newsletter. Receive updates directly in your inbox, including:
Please contact us for latest pitch deck and access to our data room.